Company intelligence / Profile preview

Ageless Regenerative Institute

Aventura, Florida, United Statesmacksoftware.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Conducting clinical trials for degenerative diseases using adipose-derived stem cells. Early results show promise for COPD, heart failure and ischemic limbs.

Therapeutic areas: NeurologyMen's Health
Modalities: Cell therapyAdipose-derived stromal vascular fraction (AD-SVF) cellsAdipose-derived mesenchymal stem cells (MSCs)
Industry: Biotech

Drug pipeline

2 assets

autologous adipose-derived stromal cells (Ageless Regenerative Institute)

Unknown

1 more asset in the full pipeline.

Request access →

Partnerships

Bioheart Inc.(2012 acquisition of adipose tech rights)Hospital Angeles Tijuana(JHACO-certified trial site)

Beyond the preview

Go deeper on Ageless Regenerative Institute.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ageless Regenerative Institute.

Explore the full profile